Entospletinib (ENTO) in Combination with Cytarabine (Ara-C) and Daunorubicin (DNR) in Newly Diagnosed (ND) Adult Patients with NPM1-Mutated and FLT3-ITD Wild-Type Acute Myeloid Leukemia (AML) Is Associated with Good Response and Survival: A P
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6200-6203
10.1182/blood-2022-167316